Niederau C - Search Results

1

Real-world effectiveness of eliglustat in treatment-naïve and switch patients enrolled in the International Collaborative Gaucher Group Gaucher Registry.

Mistry PK, Balwani M, Charrow J, Kishnani P, Niederau C, Underhill LH, McClain MR. Mistry PK, et al. Among authors: niederau c. Am J Hematol. 2020 Sep;95(9):1038-1046. doi: 10.1002/ajh.25875. Epub 2020 Jun 24. Am J Hematol. 2020. PMID: 32438452 Free PMC article. Clinical Trial.

2

Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in Europe.

Belmatoug N, Di Rocco M, Fraga C, Giraldo P, Hughes D, Lukina E, Maison-Blanche P, Merkel M, Niederau C, Plӧckinger U, Richter J, Stulnig TM, Vom Dahl S, Cox TM. Belmatoug N, et al. Among authors: niederau c. Eur J Intern Med. 2017 Jan;37:25-32. doi: 10.1016/j.ejim.2016.07.011. Epub 2016 Aug 10. Eur J Intern Med. 2017. PMID: 27522145 Free article. Review.

3

Real-world use, effectiveness and safety of anti-viral treatment in chronic hepatitis C genotype 3 infection.

Cornberg M, Petersen J, Schober A, Mauss S, Böker KH, Link R, Günther R, Serfert Y, Pfeiffer-Vornkahl H, Manns MP, Sarrazin C, Hüppe D, Berg T, Niederau C. Cornberg M, et al. Among authors: niederau c. Aliment Pharmacol Ther. 2017 Mar;45(5):688-700. doi: 10.1111/apt.13925. Epub 2017 Jan 12. Aliment Pharmacol Ther. 2017. PMID: 28078723

4

Glucocerebrosidase for treatment of Gaucher's disease: first German long-term results.

Niederau C, Holderer A, Heintges T, Strohmeyer G. Niederau C, et al. J Hepatol. 1994 Oct;21(4):610-7. doi: 10.1016/s0168-8278(94)80109-6. J Hepatol. 1994. PMID: 7814809

5

Experts' views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease.

Hamiel U, Kurolap A, Cohen IJ, Ruhrman-Shahar N, Hershkovitz T, Niederau C, Zimran A, Revel-Vilk S, Istaiti M, Cappellini MD, Baris Feldman H. Hamiel U, et al. Among authors: niederau c. Br J Haematol. 2021 Oct;195(2):e135-e137. doi: 10.1111/bjh.17693. Epub 2021 Jul 5. Br J Haematol. 2021. PMID: 34227097 Free PMC article. No abstract available.

6

The cognitive profile of type 1 Gaucher disease patients.

Biegstraaten M, Wesnes KA, Luzy C, Petakov M, Mrsic M, Niederau C, Giraldo P, Hughes D, Mehta A, Mengel KE, Hollak CE, Maródi L, van Schaik IN. Biegstraaten M, et al. Among authors: niederau c. J Inherit Metab Dis. 2012 Nov;35(6):1093-9. doi: 10.1007/s10545-012-9460-7. Epub 2012 Feb 21. J Inherit Metab Dis. 2012. PMID: 22350617 Free PMC article.

7

Gaucher's disease: a review for the internist and hepatologist.

Niederau C, Häussinger D. Niederau C, et al. Hepatogastroenterology. 2000 Jul-Aug;47(34):984-97. Hepatogastroenterology. 2000. PMID: 11020862 Review.

8

First long-term results of imiglucerase therapy of type 1 Gaucher disease.

Niederau C, vom Dahl S, Häussinger D. Niederau C, et al. Eur J Med Res. 1998 Feb 21;3(1-2):25-30. Eur J Med Res. 1998. PMID: 9512964

9

[Gaucher disease: MR evaluation of bone marrow features during treatment with enzyme replacement].

Poll LW, vom Dahl S, Koch JA, Börner D, Willers R, Cohnen M, Jung G, Scherer A, Niederau C, Häussinger D, Mödder U. Poll LW, et al. Among authors: niederau c. Rofo. 2001 Oct;173(10):931-7. doi: 10.1055/s-2001-17593. Rofo. 2001. PMID: 11588682 German.

10

Loss of vision in Gaucher's disease and its reversal by enzyme-replacement therapy.

vom Dahl S, Niederau C, Häussinger D. vom Dahl S, et al. Among authors: niederau c. N Engl J Med. 1998 May 14;338(20):1471-2. doi: 10.1056/NEJM199805143382016. N Engl J Med. 1998. PMID: 9583981 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

323 results

Search Page